Document is current
Any future updates will be listed below
-
Authors
Chen, Jie https://orcid.org/0000-0001-8483-662X
Liu, Nan
Huang, Yinpin
Wang, Yuanxun
Sun, Yuxing
Wu, Qingcui
Li, Dianrong
Gao, Shuanhu https://orcid.org/0000-0001-6919-4577
Wang, Hong-Wei https://orcid.org/0000-0001-9494-8780
Huang, Niu https://orcid.org/0000-0002-6912-033X
Qi, Xiangbing https://orcid.org/0000-0002-7139-5164
Wang, Xiaodong https://orcid.org/0000-0001-9885-356X
-
Funding
Funding for this research was provided by:
Beijing Municipal Science and Technology Commission (Z201100005320012)
Ministry of Science and Technology of the People’s Republic of China (2014CB849603)
- License Information
-
More Information
Article History
Received: 24 March 2021
Accepted: 5 October 2021
First Online: 27 October 2021
Competing interests
: The authors, Xiaodong Wang, Xiangbing Qi, Niu Huang, Hong-wei Wang, Jie Chen, Nan Liu, Yinpin Huang, Yuanxun Wang, Yuxing Sun, Qingcui Wu, and Dianrong Li have filed a provisional patent application (PCT/CN2021/082486) for the application of “Anagrelide analogs and the use thereof”. All authors declare no competing interests.
